Quality assurance of human papillomavirus (HPV) testing in the implementation of HPV primary screening in Norway: an inter-laboratory reproducibility study
Abstract Background Human papillomavirus (HPV) testing as primary screening for cervical cancer is currently being implemented in Norway in a randomized controlled fashion, involving three laboratories. As part of the quality assurance programme of the implementation, an evaluation of the inter-labo...
Main Authors: | Birgit Engesæter, Bianca van Diermen Hidle, Mona Hansen, Pia Moltu, Kjersti Mangseth Staby, Siri Borchgrevink-Persen, Olav K. Vintermyr, Stefan Lönnberg, Mari Nygård, Emiel A. M. Janssen, Philip E. Castle, Irene Kraus Christiansen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2016-11-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12879-016-2028-7 |
Similar Items
-
Is It Time to Genotype Beyond HPV16 and HPV18 for Cervical Cancer Screening?
by: Brandon Wen Bing Chua, et al.
Published: (2022-05-01) -
Methods for screening and prevention of HPV infection – a retrospective study
by: Catalina Diana Stanica, et al.
Published: (2021-03-01) -
High risk HPV infection prevalence and associated cofactors: a population-based study in female ISSSTE beneficiaries attending the HPV screening and early detection of cervical cancer program
by: K. Torres-Poveda, et al.
Published: (2019-12-01) -
Comparison of HPV testing and cervical cytology in prevention of cervical cancer
by: Klaudia Remjasz, et al.
Published: (2022-08-01) -
Comparison of HPV testing and cervical cytology in prevention of cervical cancer
by: Klaudia Remjasz, et al.
Published: (2022-08-01)